SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000891293-20-000002
Filing Date
2020-02-03
Accepted
2020-02-03 06:09:37
Documents
4
Period of Report
2020-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-krightsoffering.htm 8-K 34215
2 EXHIBIT 10.1 exhibit-101.htm EX-1 207235
3 EXHIBIT 99.1 exhibit991.htm EX-2 15183
4 exhibit991image.jpg GRAPHIC 5087
  Complete submission text file 0000891293-20-000002.txt   265083
Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121
Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100
CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-28386 | Film No.: 20566867
SIC: 2834 Pharmaceutical Preparations